研发
精心研发，造福患者
我们的研发团队努力发现、开发和提供能够改变患者人生的药物，为存在高度未满足需求的医疗领域建立新标准。用我们的创新药物消灭让人闻之色变的严重疾病：癌症、心脏和免疫系统以及血液疾病。它绝不简单，但绝对有趣。在这里，你将改写规则，抗击艰巨挑战，创造奇迹。
Explore careers in Research & Development
我们为在肿瘤学、血液学、免疫学、心血管和神经科学等核心治疗领域取得的进步感到自豪。我们前景广阔的多样化在研管线专注研究存在出色机会的治疗领域，我们相信能为这些领域的患者提供变革性药物。在开发下一代突破性治疗领域，BMS 是研发人员的不二之选。在这里，你不仅能体验有趣的工作、激动人心的职业发展，还将与来自各个领域的杰出队友合作。它可能彻底改变你的职业生涯。
Our next neuroscience breakthrough need authors
We are excited to re-enter the field of neuroscience, seeking innovative treatments for patients living with neuropsychiatric disorders such as schizophrenia and neurological conditions like Alzheimer’s disease. You can join us on this exciting journey to transform the lives of patients around the world. It may just transform your career.
Leading the way to scientific innovation for patients
PharmaVoice 100
OCTOBER 2024
Alyssa Johnsen, Head of Clinical Development, ICN has been honored for her leadership in clinical development.
Endpoints News Women in Biopharma R&D
OCTOBER 2024
Mariann Micsinai-Balan, VP, GBDS Data Science & Statistical Methodology has been featured for her outstanding contributions to our novel computational methods.
ACS Heroes of Chemistry Award
OCTOBER 2024
Our chemists are honored to be recognized for the ACS Heroes of Chemistry Award for the seventh time in the past ten years.
This year, we celebrate their dedicated work to deliver the first oral treatment for patients living with plaque psoriasis.
我们的职业故事
看看我们世界各地的研发团队成员每天如何为患者工作。
Science Firsthand: Translating the promise of cell therapy
Learn the story of how chimeric antigen receptor (CAR) T cell therapy went from hypothesis to groundbreaking treatment. Committed to improving cell therapy science, BMS is advancing a robust pipeline of cell therapies.
Science Firsthand: The pathway to drug discovery
Discover the new Bristol Myers Squibb Science Firsthand series, showcasing the pioneering path of intentional protein degraders in drug discovery and development process. Read more to experience the transformative potential for life-changing breakthroughs in patient care.
English 
Japanese 
French 
German 
Italian 
Korean 
Portuguese 
Chinese (China) 
Spanish 
Chinese (Taiwan) 
